nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—Ethinyl Estradiol—osteoporosis	0.0769	0.133	CbGbCtD
Lomitapide—CYP3A4—Estropipate—osteoporosis	0.0715	0.124	CbGbCtD
Lomitapide—CYP3A4—Calcitriol—osteoporosis	0.0715	0.124	CbGbCtD
Lomitapide—CYP3A4—Ergocalciferol—osteoporosis	0.0572	0.099	CbGbCtD
Lomitapide—ABCB1—Conjugated Estrogens—osteoporosis	0.0564	0.0978	CbGbCtD
Lomitapide—ABCB1—Estradiol—osteoporosis	0.0495	0.0859	CbGbCtD
Lomitapide—CYP3A4—Raloxifene—osteoporosis	0.0477	0.0827	CbGbCtD
Lomitapide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0461	0.0798	CbGbCtD
Lomitapide—CYP3A4—Cholecalciferol—osteoporosis	0.0368	0.0638	CbGbCtD
Lomitapide—CYP3A4—Conjugated Estrogens—osteoporosis	0.0338	0.0586	CbGbCtD
Lomitapide—CYP3A4—Estradiol—osteoporosis	0.0297	0.0514	CbGbCtD
Lomitapide—MTTP—Chylomicron-mediated lipid transport—P4HB—osteoporosis	0.0144	0.167	CbGpPWpGaD
Lomitapide—MTTP—Lipoprotein metabolism—P4HB—osteoporosis	0.00915	0.106	CbGpPWpGaD
Lomitapide—MTTP—Lipid and lipoprotein metabolism—MGLL—osteoporosis	0.00895	0.103	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—ID4—osteoporosis	0.00676	0.078	CbGpPWpGaD
Lomitapide—MTTP—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.00608	0.0703	CbGpPWpGaD
Lomitapide—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00533	0.0616	CbGpPWpGaD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00329	0.0379	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00178	0.0206	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00169	0.0195	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.00131	0.0152	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00128	0.0148	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.00109	0.0126	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.00102	0.0118	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000869	0.01	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—LEP—osteoporosis	0.000864	0.00998	CbGpPWpGaD
Lomitapide—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000852	0.00984	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PKM—osteoporosis	0.000793	0.00916	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—FDPS—osteoporosis	0.000793	0.00916	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.000762	0.0088	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PGLS—osteoporosis	0.000752	0.00868	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GPD2—osteoporosis	0.000752	0.00868	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PNP—osteoporosis	0.000687	0.00794	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ATIC—osteoporosis	0.000687	0.00794	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CA2—osteoporosis	0.000585	0.00675	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—OXCT1—osteoporosis	0.000585	0.00675	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—MGLL—osteoporosis	0.00057	0.00658	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000537	0.0062	CbGpPWpGaD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000525	0.00606	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000489	0.00565	CbGpPWpGaD
Lomitapide—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000485	0.00144	CcSEcCtD
Lomitapide—MTTP—Metabolism—IDH2—osteoporosis	0.000484	0.00559	CbGpPWpGaD
Lomitapide—Fatigue—Estropipate—osteoporosis	0.000484	0.00144	CcSEcCtD
Lomitapide—Paraesthesia—Ibandronate—osteoporosis	0.000484	0.00144	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00048	0.00143	CcSEcCtD
Lomitapide—Constipation—Estropipate—osteoporosis	0.00048	0.00143	CcSEcCtD
Lomitapide—Ill-defined disorder—Pamidronate—osteoporosis	0.00048	0.00143	CcSEcCtD
Lomitapide—Dyspepsia—Raloxifene—osteoporosis	0.000479	0.00142	CcSEcCtD
Lomitapide—Anaemia—Pamidronate—osteoporosis	0.000478	0.00142	CcSEcCtD
Lomitapide—Dyspepsia—Ibandronate—osteoporosis	0.000474	0.00141	CcSEcCtD
Lomitapide—Constipation—Alendronate—osteoporosis	0.000473	0.00141	CcSEcCtD
Lomitapide—Weight decreased—Estradiol—osteoporosis	0.000472	0.0014	CcSEcCtD
Lomitapide—Malnutrition—Zoledronate—osteoporosis	0.000472	0.0014	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000472	0.0014	CcSEcCtD
Lomitapide—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000471	0.0014	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00047	0.0014	CcSEcCtD
Lomitapide—Discomfort—Ethinyl Estradiol—osteoporosis	0.000469	0.00139	CcSEcCtD
Lomitapide—Somnolence—Calcitriol—osteoporosis	0.000469	0.00139	CcSEcCtD
Lomitapide—Decreased appetite—Ibandronate—osteoporosis	0.000468	0.00139	CcSEcCtD
Lomitapide—Malaise—Pamidronate—osteoporosis	0.000466	0.00139	CcSEcCtD
Lomitapide—Infestation NOS—Estradiol—osteoporosis	0.000466	0.00138	CcSEcCtD
Lomitapide—Infestation—Estradiol—osteoporosis	0.000466	0.00138	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000465	0.00138	CcSEcCtD
Lomitapide—Fatigue—Ibandronate—osteoporosis	0.000464	0.00138	CcSEcCtD
Lomitapide—Arthralgia—Risedronate—osteoporosis	0.000463	0.00138	CcSEcCtD
Lomitapide—Chest pain—Risedronate—osteoporosis	0.000463	0.00138	CcSEcCtD
Lomitapide—Myalgia—Risedronate—osteoporosis	0.000463	0.00138	CcSEcCtD
Lomitapide—Constipation—Ibandronate—osteoporosis	0.00046	0.00137	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00046	0.00137	CcSEcCtD
Lomitapide—Gastrointestinal pain—Estropipate—osteoporosis	0.000459	0.00137	CcSEcCtD
Lomitapide—Decreased appetite—Calcitriol—osteoporosis	0.000458	0.00136	CcSEcCtD
Lomitapide—Back pain—Zoledronate—osteoporosis	0.000457	0.00136	CcSEcCtD
Lomitapide—Feeling abnormal—Alendronate—osteoporosis	0.000456	0.00135	CcSEcCtD
Lomitapide—MTTP—Metabolism—CYP27A1—osteoporosis	0.000455	0.00526	CbGpPWpGaD
Lomitapide—Malnutrition—Conjugated Estrogens—osteoporosis	0.000455	0.00135	CcSEcCtD
Lomitapide—Muscle spasms—Zoledronate—osteoporosis	0.000454	0.00135	CcSEcCtD
Lomitapide—Dry mouth—Risedronate—osteoporosis	0.000453	0.00135	CcSEcCtD
Lomitapide—Gastrointestinal pain—Alendronate—osteoporosis	0.000452	0.00134	CcSEcCtD
Lomitapide—Infection—Ethinyl Estradiol—osteoporosis	0.000452	0.00134	CcSEcCtD
Lomitapide—Constipation—Calcitriol—osteoporosis	0.000451	0.00134	CcSEcCtD
Lomitapide—Flatulence—Conjugated Estrogens—osteoporosis	0.000448	0.00133	CcSEcCtD
Lomitapide—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000446	0.00133	CcSEcCtD
Lomitapide—Gastrointestinal pain—Raloxifene—osteoporosis	0.000445	0.00132	CcSEcCtD
Lomitapide—Diarrhoea—Etidronic acid—osteoporosis	0.000444	0.00132	CcSEcCtD
Lomitapide—Haematuria—Estradiol—osteoporosis	0.000444	0.00132	CcSEcCtD
Lomitapide—Abdominal pain—Estropipate—osteoporosis	0.000444	0.00132	CcSEcCtD
Lomitapide—Body temperature increased—Estropipate—osteoporosis	0.000444	0.00132	CcSEcCtD
Lomitapide—Feeling abnormal—Ibandronate—osteoporosis	0.000444	0.00132	CcSEcCtD
Lomitapide—MTTP—Metabolism—ACP5—osteoporosis	0.000443	0.00512	CbGpPWpGaD
Lomitapide—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000442	0.00131	CcSEcCtD
Lomitapide—Infection—Risedronate—osteoporosis	0.000441	0.00131	CcSEcCtD
Lomitapide—Hepatobiliary disease—Estradiol—osteoporosis	0.00044	0.00131	CcSEcCtD
Lomitapide—Gastrointestinal pain—Ibandronate—osteoporosis	0.00044	0.00131	CcSEcCtD
Lomitapide—Arthralgia—Pamidronate—osteoporosis	0.00044	0.00131	CcSEcCtD
Lomitapide—Myalgia—Pamidronate—osteoporosis	0.00044	0.00131	CcSEcCtD
Lomitapide—Back pain—Conjugated Estrogens—osteoporosis	0.00044	0.00131	CcSEcCtD
Lomitapide—Ill-defined disorder—Zoledronate—osteoporosis	0.000438	0.0013	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000437	0.00505	CbGpPWpGaD
Lomitapide—Abdominal pain—Alendronate—osteoporosis	0.000437	0.0013	CcSEcCtD
Lomitapide—Body temperature increased—Alendronate—osteoporosis	0.000437	0.0013	CcSEcCtD
Lomitapide—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000437	0.0013	CcSEcCtD
Lomitapide—Sinusitis—Estradiol—osteoporosis	0.000437	0.0013	CcSEcCtD
Lomitapide—Anaemia—Zoledronate—osteoporosis	0.000436	0.0013	CcSEcCtD
Lomitapide—Nervous system disorder—Risedronate—osteoporosis	0.000435	0.00129	CcSEcCtD
Lomitapide—Discomfort—Pamidronate—osteoporosis	0.000435	0.00129	CcSEcCtD
Lomitapide—Skin disorder—Risedronate—osteoporosis	0.000431	0.00128	CcSEcCtD
Lomitapide—Gastrointestinal pain—Calcitriol—osteoporosis	0.000431	0.00128	CcSEcCtD
Lomitapide—Body temperature increased—Raloxifene—osteoporosis	0.00043	0.00128	CcSEcCtD
Lomitapide—Abdominal pain—Raloxifene—osteoporosis	0.00043	0.00128	CcSEcCtD
Lomitapide—Malaise—Zoledronate—osteoporosis	0.000426	0.00127	CcSEcCtD
Lomitapide—Abdominal pain—Ibandronate—osteoporosis	0.000426	0.00127	CcSEcCtD
Lomitapide—Body temperature increased—Ibandronate—osteoporosis	0.000426	0.00127	CcSEcCtD
Lomitapide—Vertigo—Zoledronate—osteoporosis	0.000424	0.00126	CcSEcCtD
Lomitapide—Infection—Pamidronate—osteoporosis	0.000419	0.00125	CcSEcCtD
Lomitapide—Palpitations—Zoledronate—osteoporosis	0.000417	0.00124	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000417	0.00481	CbGpPWpGaD
Lomitapide—Abdominal pain—Calcitriol—osteoporosis	0.000417	0.00124	CcSEcCtD
Lomitapide—Body temperature increased—Calcitriol—osteoporosis	0.000417	0.00124	CcSEcCtD
Lomitapide—Nervous system disorder—Pamidronate—osteoporosis	0.000414	0.00123	CcSEcCtD
Lomitapide—Urinary tract disorder—Estradiol—osteoporosis	0.000413	0.00123	CcSEcCtD
Lomitapide—Vomiting—Etidronic acid—osteoporosis	0.000413	0.00123	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000412	0.00476	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—TPI1—osteoporosis	0.000412	0.00476	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000411	0.00475	CbGpPWpGaD
Lomitapide—Connective tissue disorder—Estradiol—osteoporosis	0.000411	0.00122	CcSEcCtD
Lomitapide—Urethral disorder—Estradiol—osteoporosis	0.00041	0.00122	CcSEcCtD
Lomitapide—Vertigo—Conjugated Estrogens—osteoporosis	0.000408	0.00121	CcSEcCtD
Lomitapide—Hyperhidrosis—Pamidronate—osteoporosis	0.000408	0.00121	CcSEcCtD
Lomitapide—Headache—Etidronic acid—osteoporosis	0.000407	0.00121	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000404	0.0012	CcSEcCtD
Lomitapide—Asthenia—Estropipate—osteoporosis	0.000403	0.0012	CcSEcCtD
Lomitapide—Arthralgia—Zoledronate—osteoporosis	0.000402	0.0012	CcSEcCtD
Lomitapide—Myalgia—Zoledronate—osteoporosis	0.000402	0.0012	CcSEcCtD
Lomitapide—Chest pain—Zoledronate—osteoporosis	0.000402	0.0012	CcSEcCtD
Lomitapide—Palpitations—Conjugated Estrogens—osteoporosis	0.000402	0.00119	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000399	0.00119	CcSEcCtD
Lomitapide—Paraesthesia—Risedronate—osteoporosis	0.000398	0.00118	CcSEcCtD
Lomitapide—Discomfort—Zoledronate—osteoporosis	0.000397	0.00118	CcSEcCtD
Lomitapide—Asthenia—Alendronate—osteoporosis	0.000397	0.00118	CcSEcCtD
Lomitapide—Dry mouth—Zoledronate—osteoporosis	0.000393	0.00117	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000393	0.00117	CcSEcCtD
Lomitapide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000393	0.00454	CbGpPWpGaD
Lomitapide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000392	0.00117	CcSEcCtD
Lomitapide—Dyspepsia—Risedronate—osteoporosis	0.000391	0.00116	CcSEcCtD
Lomitapide—Eye disorder—Estradiol—osteoporosis	0.000391	0.00116	CcSEcCtD
Lomitapide—Constipation—Ethinyl Estradiol—osteoporosis	0.000389	0.00116	CcSEcCtD
Lomitapide—Cardiac disorder—Estradiol—osteoporosis	0.000388	0.00115	CcSEcCtD
Lomitapide—MTTP—Metabolism—P4HB—osteoporosis	0.000387	0.00447	CbGpPWpGaD
Lomitapide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000387	0.00115	CcSEcCtD
Lomitapide—Chest pain—Conjugated Estrogens—osteoporosis	0.000387	0.00115	CcSEcCtD
Lomitapide—Myalgia—Conjugated Estrogens—osteoporosis	0.000387	0.00115	CcSEcCtD
Lomitapide—Asthenia—Ibandronate—osteoporosis	0.000386	0.00115	CcSEcCtD
Lomitapide—Nausea—Etidronic acid—osteoporosis	0.000386	0.00115	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000384	0.00114	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000384	0.00114	CcSEcCtD
Lomitapide—Diarrhoea—Estropipate—osteoporosis	0.000384	0.00114	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000383	0.00114	CcSEcCtD
Lomitapide—Infection—Zoledronate—osteoporosis	0.000383	0.00114	CcSEcCtD
Lomitapide—Fatigue—Risedronate—osteoporosis	0.000383	0.00114	CcSEcCtD
Lomitapide—MTTP—Metabolism—GAPDH—osteoporosis	0.00038	0.00439	CbGpPWpGaD
Lomitapide—Constipation—Risedronate—osteoporosis	0.000379	0.00113	CcSEcCtD
Lomitapide—Paraesthesia—Pamidronate—osteoporosis	0.000379	0.00113	CcSEcCtD
Lomitapide—Diarrhoea—Alendronate—osteoporosis	0.000378	0.00113	CcSEcCtD
Lomitapide—Asthenia—Calcitriol—osteoporosis	0.000378	0.00112	CcSEcCtD
Lomitapide—Nervous system disorder—Zoledronate—osteoporosis	0.000378	0.00112	CcSEcCtD
Lomitapide—Mediastinal disorder—Estradiol—osteoporosis	0.000377	0.00112	CcSEcCtD
Lomitapide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000375	0.00112	CcSEcCtD
Lomitapide—Chills—Estradiol—osteoporosis	0.000375	0.00111	CcSEcCtD
Lomitapide—Somnolence—Pamidronate—osteoporosis	0.000375	0.00111	CcSEcCtD
Lomitapide—Skin disorder—Zoledronate—osteoporosis	0.000374	0.00111	CcSEcCtD
Lomitapide—Hyperhidrosis—Zoledronate—osteoporosis	0.000373	0.00111	CcSEcCtD
Lomitapide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000372	0.00111	CcSEcCtD
Lomitapide—Diarrhoea—Raloxifene—osteoporosis	0.000372	0.00111	CcSEcCtD
Lomitapide—Dyspepsia—Pamidronate—osteoporosis	0.000371	0.0011	CcSEcCtD
Lomitapide—Dizziness—Estropipate—osteoporosis	0.000371	0.0011	CcSEcCtD
Lomitapide—MTTP—Metabolism—RAP1A—osteoporosis	0.00037	0.00427	CbGpPWpGaD
Lomitapide—Infection—Conjugated Estrogens—osteoporosis	0.000369	0.0011	CcSEcCtD
Lomitapide—Diarrhoea—Ibandronate—osteoporosis	0.000368	0.0011	CcSEcCtD
Lomitapide—Decreased appetite—Pamidronate—osteoporosis	0.000367	0.00109	CcSEcCtD
Lomitapide—Dizziness—Alendronate—osteoporosis	0.000366	0.00109	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000364	0.00108	CcSEcCtD
Lomitapide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000364	0.00108	CcSEcCtD
Lomitapide—Malnutrition—Estradiol—osteoporosis	0.000364	0.00108	CcSEcCtD
Lomitapide—Fatigue—Pamidronate—osteoporosis	0.000364	0.00108	CcSEcCtD
Lomitapide—Gastrointestinal pain—Risedronate—osteoporosis	0.000363	0.00108	CcSEcCtD
Lomitapide—Constipation—Pamidronate—osteoporosis	0.000361	0.00107	CcSEcCtD
Lomitapide—Diarrhoea—Calcitriol—osteoporosis	0.000361	0.00107	CcSEcCtD
Lomitapide—Skin disorder—Conjugated Estrogens—osteoporosis	0.00036	0.00107	CcSEcCtD
Lomitapide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00036	0.00107	CcSEcCtD
Lomitapide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00036	0.00107	CcSEcCtD
Lomitapide—Dizziness—Raloxifene—osteoporosis	0.00036	0.00107	CcSEcCtD
Lomitapide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000359	0.00107	CcSEcCtD
Lomitapide—Flatulence—Estradiol—osteoporosis	0.000359	0.00107	CcSEcCtD
Lomitapide—Vomiting—Estropipate—osteoporosis	0.000357	0.00106	CcSEcCtD
Lomitapide—Dizziness—Ibandronate—osteoporosis	0.000356	0.00106	CcSEcCtD
Lomitapide—Back pain—Estradiol—osteoporosis	0.000352	0.00105	CcSEcCtD
Lomitapide—Headache—Estropipate—osteoporosis	0.000352	0.00105	CcSEcCtD
Lomitapide—Vomiting—Alendronate—osteoporosis	0.000352	0.00105	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000351	0.00104	CcSEcCtD
Lomitapide—Abdominal pain—Risedronate—osteoporosis	0.000351	0.00104	CcSEcCtD
Lomitapide—Body temperature increased—Risedronate—osteoporosis	0.000351	0.00104	CcSEcCtD
Lomitapide—Muscle spasms—Estradiol—osteoporosis	0.00035	0.00104	CcSEcCtD
Lomitapide—Feeling abnormal—Pamidronate—osteoporosis	0.000348	0.00103	CcSEcCtD
Lomitapide—Headache—Alendronate—osteoporosis	0.000346	0.00103	CcSEcCtD
Lomitapide—Paraesthesia—Zoledronate—osteoporosis	0.000346	0.00103	CcSEcCtD
Lomitapide—Vomiting—Raloxifene—osteoporosis	0.000346	0.00103	CcSEcCtD
Lomitapide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000345	0.00103	CcSEcCtD
Lomitapide—Somnolence—Zoledronate—osteoporosis	0.000343	0.00102	CcSEcCtD
Lomitapide—Vomiting—Ibandronate—osteoporosis	0.000342	0.00102	CcSEcCtD
Lomitapide—Headache—Raloxifene—osteoporosis	0.000341	0.00101	CcSEcCtD
Lomitapide—Dyspepsia—Zoledronate—osteoporosis	0.000339	0.00101	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000338	0.001	CcSEcCtD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000338	0.0039	CbGpPWpGaD
Lomitapide—Ill-defined disorder—Estradiol—osteoporosis	0.000338	0.001	CcSEcCtD
Lomitapide—Headache—Ibandronate—osteoporosis	0.000337	0.001	CcSEcCtD
Lomitapide—Vomiting—Calcitriol—osteoporosis	0.000335	0.000996	CcSEcCtD
Lomitapide—Decreased appetite—Zoledronate—osteoporosis	0.000335	0.000996	CcSEcCtD
Lomitapide—Nausea—Estropipate—osteoporosis	0.000334	0.000992	CcSEcCtD
Lomitapide—Abdominal pain—Pamidronate—osteoporosis	0.000333	0.000991	CcSEcCtD
Lomitapide—Body temperature increased—Pamidronate—osteoporosis	0.000333	0.000991	CcSEcCtD
Lomitapide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000333	0.000991	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000333	0.000989	CcSEcCtD
Lomitapide—Fatigue—Zoledronate—osteoporosis	0.000332	0.000988	CcSEcCtD
Lomitapide—Headache—Calcitriol—osteoporosis	0.00033	0.000982	CcSEcCtD
Lomitapide—Somnolence—Conjugated Estrogens—osteoporosis	0.00033	0.000981	CcSEcCtD
Lomitapide—Constipation—Zoledronate—osteoporosis	0.00033	0.00098	CcSEcCtD
Lomitapide—Nausea—Alendronate—osteoporosis	0.000329	0.000977	CcSEcCtD
Lomitapide—Malaise—Estradiol—osteoporosis	0.000328	0.000975	CcSEcCtD
Lomitapide—Vertigo—Estradiol—osteoporosis	0.000327	0.000972	CcSEcCtD
Lomitapide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000327	0.000971	CcSEcCtD
Lomitapide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000327	0.000971	CcSEcCtD
Lomitapide—Nausea—Raloxifene—osteoporosis	0.000323	0.000961	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000323	0.00373	CbGpPWpGaD
Lomitapide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000323	0.000959	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—IL6—osteoporosis	0.000322	0.00372	CbGpPWpGaD
Lomitapide—Palpitations—Estradiol—osteoporosis	0.000322	0.000956	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00032	0.000952	CcSEcCtD
Lomitapide—Fatigue—Conjugated Estrogens—osteoporosis	0.00032	0.000951	CcSEcCtD
Lomitapide—Nausea—Ibandronate—osteoporosis	0.00032	0.000951	CcSEcCtD
Lomitapide—Asthenia—Risedronate—osteoporosis	0.000318	0.000947	CcSEcCtD
Lomitapide—Feeling abnormal—Zoledronate—osteoporosis	0.000318	0.000944	CcSEcCtD
Lomitapide—Constipation—Conjugated Estrogens—osteoporosis	0.000317	0.000943	CcSEcCtD
Lomitapide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000315	0.000937	CcSEcCtD
Lomitapide—Nausea—Calcitriol—osteoporosis	0.000313	0.000931	CcSEcCtD
Lomitapide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000311	0.000926	CcSEcCtD
Lomitapide—Chest pain—Estradiol—osteoporosis	0.00031	0.000921	CcSEcCtD
Lomitapide—Arthralgia—Estradiol—osteoporosis	0.00031	0.000921	CcSEcCtD
Lomitapide—Myalgia—Estradiol—osteoporosis	0.00031	0.000921	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000308	0.000915	CcSEcCtD
Lomitapide—Discomfort—Estradiol—osteoporosis	0.000306	0.00091	CcSEcCtD
Lomitapide—Body temperature increased—Zoledronate—osteoporosis	0.000305	0.000906	CcSEcCtD
Lomitapide—Abdominal pain—Zoledronate—osteoporosis	0.000305	0.000906	CcSEcCtD
Lomitapide—Diarrhoea—Risedronate—osteoporosis	0.000304	0.000903	CcSEcCtD
Lomitapide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000303	0.000902	CcSEcCtD
Lomitapide—Dry mouth—Estradiol—osteoporosis	0.000303	0.000901	CcSEcCtD
Lomitapide—Asthenia—Pamidronate—osteoporosis	0.000303	0.0009	CcSEcCtD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000301	0.00348	CbGpPWpGaD
Lomitapide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000301	0.000895	CcSEcCtD
Lomitapide—MTTP—Metabolism—ENO1—osteoporosis	0.000299	0.00346	CbGpPWpGaD
Lomitapide—Infection—Estradiol—osteoporosis	0.000295	0.000877	CcSEcCtD
Lomitapide—MTTP—Metabolism—PSMA2—osteoporosis	0.000295	0.00341	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PSMA5—osteoporosis	0.000295	0.00341	CbGpPWpGaD
Lomitapide—Dizziness—Risedronate—osteoporosis	0.000293	0.000872	CcSEcCtD
Lomitapide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000293	0.000872	CcSEcCtD
Lomitapide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000293	0.000872	CcSEcCtD
Lomitapide—Nervous system disorder—Estradiol—osteoporosis	0.000291	0.000866	CcSEcCtD
Lomitapide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000289	0.00086	CcSEcCtD
Lomitapide—Diarrhoea—Pamidronate—osteoporosis	0.000289	0.000858	CcSEcCtD
Lomitapide—Skin disorder—Estradiol—osteoporosis	0.000288	0.000858	CcSEcCtD
Lomitapide—Hyperhidrosis—Estradiol—osteoporosis	0.000287	0.000853	CcSEcCtD
Lomitapide—Headache—Ethinyl Estradiol—osteoporosis	0.000285	0.000848	CcSEcCtD
Lomitapide—Vomiting—Risedronate—osteoporosis	0.000282	0.000839	CcSEcCtD
Lomitapide—Dizziness—Pamidronate—osteoporosis	0.000279	0.000829	CcSEcCtD
Lomitapide—Headache—Risedronate—osteoporosis	0.000278	0.000827	CcSEcCtD
Lomitapide—Asthenia—Zoledronate—osteoporosis	0.000276	0.000822	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000271	0.00313	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000271	0.000804	CcSEcCtD
Lomitapide—Nausea—Ethinyl Estradiol—osteoporosis	0.00027	0.000804	CcSEcCtD
Lomitapide—Vomiting—Pamidronate—osteoporosis	0.000268	0.000797	CcSEcCtD
Lomitapide—Paraesthesia—Estradiol—osteoporosis	0.000267	0.000793	CcSEcCtD
Lomitapide—Asthenia—Conjugated Estrogens—osteoporosis	0.000266	0.000791	CcSEcCtD
Lomitapide—Headache—Pamidronate—osteoporosis	0.000264	0.000786	CcSEcCtD
Lomitapide—Somnolence—Estradiol—osteoporosis	0.000264	0.000785	CcSEcCtD
Lomitapide—Diarrhoea—Zoledronate—osteoporosis	0.000264	0.000784	CcSEcCtD
Lomitapide—Nausea—Risedronate—osteoporosis	0.000264	0.000784	CcSEcCtD
Lomitapide—Dyspepsia—Estradiol—osteoporosis	0.000261	0.000777	CcSEcCtD
Lomitapide—Decreased appetite—Estradiol—osteoporosis	0.000258	0.000767	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000256	0.000762	CcSEcCtD
Lomitapide—Fatigue—Estradiol—osteoporosis	0.000256	0.000761	CcSEcCtD
Lomitapide—Dizziness—Zoledronate—osteoporosis	0.000255	0.000758	CcSEcCtD
Lomitapide—Constipation—Estradiol—osteoporosis	0.000254	0.000755	CcSEcCtD
Lomitapide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000254	0.000755	CcSEcCtD
Lomitapide—Nausea—Pamidronate—osteoporosis	0.000251	0.000745	CcSEcCtD
Lomitapide—Dizziness—Conjugated Estrogens—osteoporosis	0.000245	0.000729	CcSEcCtD
Lomitapide—Vomiting—Zoledronate—osteoporosis	0.000245	0.000728	CcSEcCtD
Lomitapide—Feeling abnormal—Estradiol—osteoporosis	0.000245	0.000728	CcSEcCtD
Lomitapide—Gastrointestinal pain—Estradiol—osteoporosis	0.000243	0.000722	CcSEcCtD
Lomitapide—Headache—Zoledronate—osteoporosis	0.000241	0.000718	CcSEcCtD
Lomitapide—MTTP—Metabolism—CYP19A1—osteoporosis	0.000239	0.00276	CbGpPWpGaD
Lomitapide—Vomiting—Conjugated Estrogens—osteoporosis	0.000236	0.000701	CcSEcCtD
Lomitapide—Abdominal pain—Estradiol—osteoporosis	0.000235	0.000698	CcSEcCtD
Lomitapide—Body temperature increased—Estradiol—osteoporosis	0.000235	0.000698	CcSEcCtD
Lomitapide—Headache—Conjugated Estrogens—osteoporosis	0.000232	0.000691	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.00023	0.00266	CbGpPWpGaD
Lomitapide—Nausea—Zoledronate—osteoporosis	0.000229	0.00068	CcSEcCtD
Lomitapide—Nausea—Conjugated Estrogens—osteoporosis	0.00022	0.000655	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000219	0.00253	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000218	0.00251	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000216	0.0025	CbGpPWpGaD
Lomitapide—Asthenia—Estradiol—osteoporosis	0.000213	0.000633	CcSEcCtD
Lomitapide—Diarrhoea—Estradiol—osteoporosis	0.000203	0.000604	CcSEcCtD
Lomitapide—Dizziness—Estradiol—osteoporosis	0.000196	0.000584	CcSEcCtD
Lomitapide—MTTP—Metabolism—ADCY5—osteoporosis	0.000195	0.00226	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GPX1—osteoporosis	0.000195	0.00225	CbGpPWpGaD
Lomitapide—Vomiting—Estradiol—osteoporosis	0.000189	0.000561	CcSEcCtD
Lomitapide—Headache—Estradiol—osteoporosis	0.000186	0.000553	CcSEcCtD
Lomitapide—MTTP—Metabolism—MTHFR—osteoporosis	0.00018	0.00208	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000179	0.00207	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000178	0.00205	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000177	0.00204	CbGpPWpGaD
Lomitapide—Nausea—Estradiol—osteoporosis	0.000176	0.000524	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000155	0.00179	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	0.000145	0.00168	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—POMC—osteoporosis	0.000144	0.00166	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000132	0.00152	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL1B—osteoporosis	0.000127	0.00147	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000122	0.00141	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000107	0.00123	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TGFB1—osteoporosis	9.88e-05	0.00114	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	9.43e-05	0.00109	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	9.4e-05	0.00109	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	9.3e-05	0.00107	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TNF—osteoporosis	9.23e-05	0.00107	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—FDPS—osteoporosis	8.67e-05	0.001	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PKM—osteoporosis	8.67e-05	0.001	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PGLS—osteoporosis	8.22e-05	0.00095	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GPD2—osteoporosis	8.22e-05	0.00095	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	8.14e-05	0.00094	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PNP—osteoporosis	7.52e-05	0.000869	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ATIC—osteoporosis	7.52e-05	0.000869	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—OXCT1—osteoporosis	6.4e-05	0.000739	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CA2—osteoporosis	6.4e-05	0.000739	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MGLL—osteoporosis	6.23e-05	0.00072	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—POMC—osteoporosis	5.67e-05	0.000654	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PKM—osteoporosis	5.34e-05	0.000617	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—FDPS—osteoporosis	5.34e-05	0.000617	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—IDH2—osteoporosis	5.3e-05	0.000612	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GPD2—osteoporosis	5.07e-05	0.000585	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PGLS—osteoporosis	5.07e-05	0.000585	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP27A1—osteoporosis	4.98e-05	0.000575	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.89e-05	0.000565	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.88e-05	0.000563	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ACP5—osteoporosis	4.85e-05	0.00056	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ATIC—osteoporosis	4.63e-05	0.000535	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PNP—osteoporosis	4.63e-05	0.000535	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.57e-05	0.000527	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.55e-05	0.000526	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TPI1—osteoporosis	4.51e-05	0.00052	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—P4HB—osteoporosis	4.24e-05	0.000489	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GAPDH—osteoporosis	4.16e-05	0.00048	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—RAP1A—osteoporosis	4.05e-05	0.000468	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CA2—osteoporosis	3.94e-05	0.000455	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—OXCT1—osteoporosis	3.94e-05	0.000455	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MGLL—osteoporosis	3.84e-05	0.000443	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ENO1—osteoporosis	3.27e-05	0.000378	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—IDH2—osteoporosis	3.26e-05	0.000377	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PSMA2—osteoporosis	3.23e-05	0.000373	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PSMA5—osteoporosis	3.23e-05	0.000373	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.07e-05	0.000354	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ACP5—osteoporosis	2.99e-05	0.000345	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TPI1—osteoporosis	2.78e-05	0.000321	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP19A1—osteoporosis	2.62e-05	0.000302	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—P4HB—osteoporosis	2.61e-05	0.000301	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GAPDH—osteoporosis	2.56e-05	0.000296	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—RAP1A—osteoporosis	2.5e-05	0.000288	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ADCY5—osteoporosis	2.14e-05	0.000247	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GPX1—osteoporosis	2.13e-05	0.000246	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ENO1—osteoporosis	2.02e-05	0.000233	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PSMA2—osteoporosis	1.99e-05	0.00023	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PSMA5—osteoporosis	1.99e-05	0.00023	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MTHFR—osteoporosis	1.97e-05	0.000227	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.61e-05	0.000186	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—POMC—osteoporosis	1.57e-05	0.000182	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ADCY5—osteoporosis	1.32e-05	0.000152	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GPX1—osteoporosis	1.31e-05	0.000152	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MTHFR—osteoporosis	1.21e-05	0.00014	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—POMC—osteoporosis	9.69e-06	0.000112	CbGpPWpGaD
